An important factor in apceth Biopharma’s research and development strategy is cooperation with renowned clinical, academic and research organizations. Some of the world’s leading experts in the field of cell and gene therapy, oncology, immune oncology, immunomodulation and other relevant disease areas participate in our efforts to develop efficient, safe and better tolerable MSC-based gene therapeutics.
This approach strengthens apceth Biopharma’s R&D work. In addition, partnerships with international biotech companies complement pharmaceutical development of our therapeutics by providing not only state-of-the-art expertise but also platform technologies.
MEMBERSHIPS IN INDUSTRIAL ASSOCIATIONS
Verband Forschender Arzneimittelhersteller e.v. (vfa)
Dr. Guenther, apceth Biopharma’s CEO, is a member of the vfa bio’s executive board.